NCT01191918View on ClinicalTrials.gov

The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania

PHASE4CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Bipolar DisorderMania
Interventions
DRUG

Donepezil and Lithium

Donepezil dose will be started at 5mg/d and increased to 10 mg/d in 1 week.

DRUG

Placebo plus Lithium

All Listed Sponsors
collaborator

The Davis Foundations

OTHER

lead

Shanghai Mental Health Center

OTHER

NCT01191918 - The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania | Biotech Hunter | Biotech Hunter